Associated Papers
Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson's Disease.
Flores-Ocampo V et al.
Genes, 2025
Cytosolic retention of HtrA2 during mitochondrial protein import stress triggers the DELE1-HRI pathway.
Bi PY et al.
Communications Biology, 2024
Post-translational modification and mitochondrial function in Parkinson's disease.
Luo S et al.
Frontiers in Molecular Neuroscience, 2023
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals.
Cao Y et al.
Cell Research, 2020
32355288 (PubMed )
Supplement: 41422_2020_322_MOESM14_ESM.xlsx › S7
Genetic testing of FUS, HTRA2, and TENM4 genes in Chinese patients with essential tremor.
Yan YP et al.
Cns Neuroscience & Therapeutics, 2020
Generation of a human iPSC line CIBi007-A from a patient with young-onset Parkinson's disease carrying variants in PRKN and HTRA2.
Yan Y et al.
Stem Cell Research, 2020
Mitochondrial HTRA2 Plays a Positive, Protective Role in Dictyostelium discoideum but Is Cytotoxic When Overexpressed.
Chen S et al.
Genes, 2018
HTRA2 variations in Taiwanese Parkinson's disease.
Chen CM et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2014
Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
Lin CH et al.
Human Genetics, 2011
Select a paper to view details